• Je něco špatně v tomto záznamu ?

Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-a]pyridine Structure

I. Mejdrová, J. Dušek, K. Škach, A. Stefela, J. Skoda, K. Chalupský, K. Dohnalová, I. Pavkova, T. Kronenberger, A. Rashidian, L. Smutná, V. Duchoslav, T. Smutny, P. Pávek, R. Nencka

. 2023 ; 66 (4) : 2422-2456. [pub] 20230209

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004118

The nuclear constitutive androstane receptor (CAR, NR1I3) plays significant roles in many hepatic functions, such as fatty acid oxidation, biotransformation, liver regeneration, as well as clearance of steroid hormones, cholesterol, and bilirubin. CAR has been proposed as a hypothetical target receptor for metabolic or liver disease therapy. Currently known prototype high-affinity human CAR agonists such as CITCO (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime) have limited selectivity, activating the pregnane X receptor (PXR) receptor, a related receptor of the NR1I subfamily. We have discovered several derivatives of 3-(1H-1,2,3-triazol-4-yl)imidazo[1,2-a]pyridine that directly activate human CAR in nanomolar concentrations. While compound 39 regulates CAR target genes in humanized CAR mice as well as human hepatocytes, it does not activate other nuclear receptors and is nontoxic in cellular and genotoxic assays as well as in rodent toxicity studies. Our findings concerning potent human CAR agonists with in vivo activity reinforce the role of CAR as a possible therapeutic target.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004118
003      
CZ-PrNML
005      
20240612112009.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acs.jmedchem.2c01140 $2 doi
035    __
$a (PubMed)36756805
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mejdrová, Ivana $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
245    10
$a Discovery of Novel Human Constitutive Androstane Receptor Agonists with the Imidazo[1,2-a]pyridine Structure / $c I. Mejdrová, J. Dušek, K. Škach, A. Stefela, J. Skoda, K. Chalupský, K. Dohnalová, I. Pavkova, T. Kronenberger, A. Rashidian, L. Smutná, V. Duchoslav, T. Smutny, P. Pávek, R. Nencka
520    9_
$a The nuclear constitutive androstane receptor (CAR, NR1I3) plays significant roles in many hepatic functions, such as fatty acid oxidation, biotransformation, liver regeneration, as well as clearance of steroid hormones, cholesterol, and bilirubin. CAR has been proposed as a hypothetical target receptor for metabolic or liver disease therapy. Currently known prototype high-affinity human CAR agonists such as CITCO (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime) have limited selectivity, activating the pregnane X receptor (PXR) receptor, a related receptor of the NR1I subfamily. We have discovered several derivatives of 3-(1H-1,2,3-triazol-4-yl)imidazo[1,2-a]pyridine that directly activate human CAR in nanomolar concentrations. While compound 39 regulates CAR target genes in humanized CAR mice as well as human hepatocytes, it does not activate other nuclear receptors and is nontoxic in cellular and genotoxic assays as well as in rodent toxicity studies. Our findings concerning potent human CAR agonists with in vivo activity reinforce the role of CAR as a possible therapeutic target.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    12
$a konstitutivní androstanový receptor $x agonisté $x chemie $7 D000090702
650    _2
$a hepatocyty $x účinky léků $x metabolismus $7 D022781
650    _2
$a pyridiny $x farmakologie $7 D011725
650    _2
$a receptory cytoplazmatické a nukleární $x metabolismus $7 D018160
650    12
$a steroidní receptory $x agonisté $x chemie $7 D011987
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dušek, Jan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic $7 xx0318365
700    1_
$a Škach, Kryštof $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $1 https://orcid.org/0000000275586961
700    1_
$a Stefela, Alžbeta $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Skoda, Josef $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Chalupský, Karel $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic
700    1_
$a Dohnalová, Klára $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic $u 1st Medical Faculty, Charles University, Katerinska 32, 112 08 Prague, Czech Republic
700    1_
$a Pavkova, Ivona $u Faculty of Military Health Sciences, University of Defense, Trebeska 1575, 500 01 Hradec Kralove, Czech Republic $1 https://orcid.org/000000018241479X $7 xx0135762
700    1_
$a Kronenberger, Thales $u Department of Internal Medicine VIII, University Hospital of Tübingen, 72076 Tübingen, Germany $u School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio, Finland $u Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität, 72076 Tübingen, Germany
700    1_
$a Rashidian, Azam $u Department of Internal Medicine VIII, University Hospital of Tübingen, 72076 Tübingen, Germany
700    1_
$a Smutná, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Duchoslav, Vojtěch $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
700    1_
$a Smutny, Tomas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Pávek, Petr $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Nencka, Radim $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic $1 https://orcid.org/0000000161670380
773    0_
$w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 66, č. 4 (2023), s. 2422-2456
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36756805 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20240612112010 $b ABA008
999    __
$a ok $b bmc $g 1924653 $s 1190327
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 66 $c 4 $d 2422-2456 $e 20230209 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace